Addex Pharmaceuticals Raises CHF40 million-SR One and Roche Venture Funds invest in Series C Private Financing

Addex commences Phase II clinical trials programme with ADX10059

Addex Pharmaceuticals Initiates Phase I Trials with ADX10059, a novel compound intended for Anxiety and Migraine

Addex Pharmaceuticals named by tornado insider among europe's top 100 private tech companies

Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease

Addex Pharmaceuticals lauréate du Prix de la Jeune Industrie de Genève

Addex Pharmaceuticals Completes Largest ever European Biotech Series B Fund Raising

Addex Pharmaceuticals Signs Three year Clinical Development Partnership with Fulcrum Pharma Plc

CeNeS Announces Phase II Drug Deal with Addex Pharmaceuticals

Addex Pharmaceuticals Attracts Venture Funding From Leading European VC Firms